News · Approval
1,551 stories
Oct 11, 26The 2026 Biotech Graveyard
Oct 9, 26How we picked the Fierce 15
Oct 8, 26Opinion: England and other nations are on the path toward eliminating hepatitis C. Why not the U.S.?
Oct 8, 26Ono pays $80M for regional rights to trio of Biohaven IgG degraders, including phase 3 Grave’s asset